<!DOCTYPE html>
<html lang="zh-CN">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0">
    <title>ç§‘ç ”æ—¥æŠ¥ - 2025-12-19</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, "Noto Sans", sans-serif, "Apple Color Emoji", "Segoe UI Emoji";
            line-height: 1.8;
            color: #2c3e50;
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
            padding: 15px;
            font-size: 16px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
            background: white;
            padding: 35px;
            border-radius: 16px;
            box-shadow: 0 10px 40px rgba(0,0,0,0.1);
        }

        /* æ ‡é¢˜ä¼˜åŒ– */
        h1 {
            color: #1a202c;
            font-size: 2em;
            border-bottom: 4px solid #667eea;
            padding-bottom: 15px;
            margin-bottom: 25px;
            font-weight: 700;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            background-clip: text;
        }

        h2 {
            color: #2d3748;
            font-size: 1.5em;
            margin-top: 40px;
            margin-bottom: 20px;
            padding-left: 15px;
            border-left: 5px solid #667eea;
            font-weight: 600;
        }

        h3 {
            color: #4a5568;
            font-size: 1.25em;
            margin-top: 28px;
            margin-bottom: 14px;
            font-weight: 600;
        }

        /* åˆ†ç±»æµè§ˆæŠ˜å åŠŸèƒ½ */
        details {
            margin: 20px 0;
            border-radius: 8px;
            overflow: hidden;
        }

        details summary {
            cursor: pointer;
            padding: 15px 20px;
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            color: #2d3748;
            font-size: 1.25em;
            font-weight: 600;
            text-align: right;
            direction: rtl;
            border-right: 5px solid #667eea;
            transition: all 0.3s ease;
            list-style: none;
            user-select: none;
        }

        details summary * {
            direction: ltr;
        }

        details summary::-webkit-details-marker {
            display: none;
        }

        details summary::before {
            content: 'â–¶';
            display: inline-block;
            margin-left: 10px;
            transition: transform 0.3s ease;
            font-size: 0.8em;
        }

        details[open] summary::before {
            transform: rotate(90deg);
        }

        details summary:hover {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            box-shadow: 0 4px 12px rgba(102, 126, 234, 0.3);
        }

        details[open] summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            border-right-color: white;
        }

        details .details-content {
            padding: 20px;
            background: white;
            border: 1px solid #e9ecef;
            border-top: none;
        }

        h4 {
            color: #718096;
            font-size: 1.1em;
            margin-top: 22px;
            margin-bottom: 12px;
            font-weight: 600;
        }

        p {
            margin-bottom: 16px;
            line-height: 1.8;
        }

        blockquote {
            background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%);
            border-left: 4px solid #667eea;
            padding: 18px 22px;
            margin: 22px 0;
            border-radius: 8px;
            color: #4a5568;
            font-size: 0.95em;
            box-shadow: 0 2px 8px rgba(0,0,0,0.05);
        }

        blockquote p {
            margin-bottom: 8px;
        }

        blockquote p:last-child {
            margin-bottom: 0;
        }

        blockquote em {
            font-style: normal;
            color: #718096;
            font-size: 0.9em;
        }

        blockquote a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        blockquote a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* é¡¶éƒ¨ç½²åï¼ˆå±…å³ï¼‰ */
        .powered-by-top {
            text-align: right;
            font-size: 0.85em;
            color: #718096;
            font-style: italic;
            margin: 12px 0;
            padding-right: 5px;
        }

        .powered-by-top a {
            color: #667eea;
            font-weight: 500;
            border-bottom: 1px solid rgba(102, 126, 234, 0.3);
        }

        .powered-by-top a:hover {
            color: #764ba2;
            border-bottom-color: #764ba2;
        }

        /* AI æ€»ç»“åŒºåŸŸä¼˜åŒ– */
        .ai-summary {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 28px;
            border-radius: 16px;
            margin: 30px 0;
            box-shadow: 0 12px 35px rgba(102, 126, 234, 0.35);
            position: relative;
            overflow: hidden;
        }

        .ai-summary::before {
            content: '';
            position: absolute;
            top: -50%;
            right: -50%;
            width: 200%;
            height: 200%;
            background: radial-gradient(circle, rgba(255,255,255,0.1) 0%, transparent 70%);
            pointer-events: none;
        }

        .ai-summary h2 {
            color: white;
            border-left: none;
            border-right: none;
            margin-top: 0;
            margin-bottom: 18px;
            padding-left: 15px;
            padding-right: 0;
            text-align: left;
            direction: ltr;
        }

        .ai-summary h3 {
            color: #f0f0f0;
            margin-top: 18px;
            border-right: 3px solid rgba(255,255,255,0.5);
            padding-right: 12px;
            padding-left: 0;
            text-align: right;
            direction: rtl;
        }

        .ai-summary h3 * {
            direction: ltr;
        }

        .ai-summary blockquote {
            background: rgba(255,255,255,0.15);
            border-left-color: white;
            color: white;
            backdrop-filter: blur(10px);
        }

        .ai-summary p {
            color: white;
        }

        .ai-summary strong {
            color: #fff;
            font-weight: 600;
        }

        ul, ol {
            margin-left: 28px;
            margin-bottom: 18px;
        }

        li {
            margin-bottom: 12px;
            line-height: 1.8;
        }

        /* é“¾æ¥ä¼˜åŒ– */
        a {
            color: #667eea;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: all 0.3s ease;
            font-weight: 500;
        }

        a:hover {
            border-bottom-color: #667eea;
            color: #764ba2;
        }

        /* è¡¨æ ¼ä¼˜åŒ– */
        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            box-shadow: 0 2px 12px rgba(0,0,0,0.08);
            border-radius: 10px;
            overflow: hidden;
        }

        th, td {
            border: 1px solid #e2e8f0;
            padding: 14px 18px;
            text-align: left;
        }

        th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            font-weight: 600;
            font-size: 0.95em;
        }

        tr:nth-child(even) {
            background: #f8f9fa;
        }

        tr:hover {
            background: #e9ecef;
            transition: background 0.3s ease;
        }

        /* å…³é”®è¯ç»Ÿè®¡è¡¨æ ¼ç‰¹æ®Šæ ·å¼ï¼ˆæ›´ç´§å‡‘ï¼‰ */
        .keywords-table {
            font-size: 0.9em;
            max-width: 600px;
        }

        .keywords-table th,
        .keywords-table td {
            padding: 10px 14px;
        }

        .keywords-table th {
            font-size: 0.9em;
        }

        hr {
            border: none;
            border-top: 2px solid #e2e8f0;
            margin: 40px 0;
        }

        strong {
            color: #2d3748;
            font-weight: 600;
        }

        code {
            background: #f1f5f9;
            padding: 3px 8px;
            border-radius: 5px;
            font-family: "SF Mono", Monaco, Consolas, "Courier New", monospace;
            font-size: 0.9em;
            color: #e53e3e;
        }

        /* ç¾åŒ–æ»šåŠ¨æ¡ */
        ::-webkit-scrollbar {
            width: 8px;
            height: 8px;
        }

        ::-webkit-scrollbar-track {
            background: #f1f1f1;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb {
            background: #667eea;
            border-radius: 4px;
        }

        ::-webkit-scrollbar-thumb:hover {
            background: #764ba2;
        }

        /* ç§»åŠ¨ç«¯ä¼˜åŒ– */
        @media (max-width: 768px) {
            body {
                padding: 8px;
                font-size: 15px;
            }

            .container {
                padding: 22px 18px;
                border-radius: 12px;
            }

            h1 {
                font-size: 1.6em;
                padding-bottom: 12px;
                margin-bottom: 20px;
            }

            h2 {
                font-size: 1.3em;
                margin-top: 30px;
                padding-left: 12px;
            }

            h3 {
                font-size: 1.15em;
            }

            h4 {
                font-size: 1.05em;
            }

            blockquote {
                padding: 14px 16px;
                margin: 18px 0;
            }

            .ai-summary {
                padding: 20px;
                margin: 22px 0;
            }

            .ai-summary-header {
                flex-direction: column;
                align-items: flex-start;
            }

            .powered-by {
                margin-left: 0;
                margin-top: 8px;
            }

            table {
                font-size: 0.85em;
            }

            th, td {
                padding: 10px 12px;
            }

            .keywords-table {
                font-size: 0.8em;
            }

            .keywords-table th,
            .keywords-table td {
                padding: 8px 10px;
            }

            ul, ol {
                margin-left: 22px;
            }
        }

        /* è¶…å°å±å¹• */
        @media (max-width: 480px) {
            body {
                font-size: 14px;
                padding: 5px;
            }

            .container {
                padding: 18px 14px;
            }

            h1 {
                font-size: 1.4em;
            }

            h2 {
                font-size: 1.2em;
            }

            .ai-summary {
                padding: 16px;
            }

            .powered-by {
                font-size: 0.7em;
            }
        }

        /* å¹³æ»‘æ»šåŠ¨ */
        html {
            scroll-behavior: smooth;
        }

        /* æé«˜å¯ç‚¹å‡»åŒºåŸŸ */
        @media (pointer: coarse) {
            a {
                padding: 4px 0;
                display: inline-block;
            }
        }

        /* æ‰“å°ä¼˜åŒ– */
        @media print {
            body {
                background: white;
                padding: 0;
            }

            .container {
                box-shadow: none;
                max-width: 100%;
            }

            .ai-summary {
                background: #f5f5f5;
                color: black;
                box-shadow: none;
            }

            .ai-summary h2,
            .ai-summary h3,
            .ai-summary p,
            .ai-summary strong {
                color: black;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <h1>ğŸ“… Daily Report - 2025-12-19</h1>
<blockquote>
<p>ä»Šæ—¥ç­›é€‰å‡º <strong>100</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p>
</blockquote>
<div class="powered-by-top">Powered by <a href="https://kyplus.de" target="_blank" rel="noopener noreferrer">ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href="https://claude.ai" target="_blank" rel="noopener noreferrer">Claude</a></div>

<hr />
<div class="ai-summary">
                <h2>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2>
                <h3>ğŸ§¬ æ•°æ®å‰æ²¿</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å•ç»†èƒåˆ†è¾¨ç‡æ­ç¤ºå…ç–«æ£€æŸ¥ç‚¹é˜»æ»è€è¯ä¸­Tç»†èƒè€—ç«­çš„è½¬å½•è°ƒæ§æœºåˆ¶ï¼›é«˜å¼ºåº¦é—´æ­‡è®­ç»ƒï¼ˆHIITï¼‰é€šè¿‡ä¹³é…¸ä½œä¸ºä»£è°¢-è¡¨è§‚é—ä¼ ä¿¡å·é‡å¡‘éª¨éª¼è‚Œã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
*   <strong>è‚¿ç˜¤å…ç–«ä¸æ²»ç–—è€è¯</strong>ï¼šè§£æå…ç–«æ£€æŸ¥ç‚¹é˜»æ»è€è¯ä¸­çš„Tç»†èƒè€—ç«­ã€MEKæŠ‘åˆ¶å‰‚åœ¨KRASçªå˜è‚ºç™Œä¸­çš„æŠ—è‚¿ç˜¤å…ç–«å¢å¼ºä½œç”¨ã€çº³ç±³ç–—æ³•é€†è½¬èƒ°è…ºç™Œå…ç–«æŠ‘åˆ¶æ€§å·¨å™¬ç»†èƒã€ADCè€è¯æœºåˆ¶åŠé¶å‘ç­–ç•¥ã€ä»¥åŠè‚¿ç˜¤å†…åœ¨å› ç´ è°ƒæ§åµå·¢ç™Œå…ç–«ååº”ã€‚<br />
*   <strong>ä»£è°¢ä¸è¡¨è§‚é—ä¼ è°ƒæ§</strong>ï¼šç ”ç©¶ä¹³é…¸åœ¨HIITè¯±å¯¼éª¨éª¼è‚Œç”²åŸºåŒ–ç»„å’Œè½¬å½•ç»„é‡å¡‘ä¸­çš„ä½œç”¨ï¼Œä»¥åŠMRPL37å¯¹è‚ç»†èƒç™Œè¿›å±•çš„å½±å“ã€‚<br />
*   <strong>ç¥ç»ç§‘å­¦ä¸ç–¾ç—…</strong>ï¼šæ¢ç´¢è„‘è¡°è€çš„è¡¨è§‚é—ä¼ ç‰¹å¾ï¼Œä»¥åŠåˆ›ä¼¤ååº”æ¿€éšœç¢ï¼ˆPTSDï¼‰ä¸­æµ·é©¬ä½“çš„å…ç–«å¤±è¡¡ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
*   <strong>å•ç»†èƒå¤šç»„å­¦ç»“åˆ</strong>ï¼šåˆ©ç”¨å•ç»†èƒRNAæµ‹åºï¼ˆscRNA-seqï¼‰å’Œå•ç»†èƒATACæµ‹åºï¼ˆscATAC-seqï¼‰è§£æå¤æ‚çš„ç»†èƒå¼‚è´¨æ€§ã€‚<br />
*   <strong>ç©ºé—´è½¬å½•ç»„å­¦</strong>ï¼šVisiumç©ºé—´è½¬å½•ç»„å­¦æŠ€æœ¯ç”¨äºåˆ†æè„‘æŸä¼¤å’Œè‚è„å†ç”Ÿè¿‡ç¨‹ä¸­çš„ç»†èƒå¾®ç¯å¢ƒã€‚</p>
<h3>ğŸ§ª åšå®¢æ›´æ–°</h3>
<blockquote>
<p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š<br />
å•ç»†èƒè½¬å½•ç»„å­¦æŠ€æœ¯ï¼ˆRoCK and ROIï¼‰é€šè¿‡å¤šé‡å¯Œé›†å’ŒåŒºåŸŸç‰¹å¼‚æ€§æµ‹åºï¼Œæ˜¾è‘—æå‡äº†å•ç»†èƒRNAæµ‹åºåˆ†è¾¨ç‡ï¼Œæ­ç¤ºå…³é”®è½¬å½•æœ¬å’Œæ„Ÿå…´è¶£åŒºåŸŸã€‚</p>
</blockquote>
<p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š<br />
-  å•ç»†èƒRNAæµ‹åºæ­ç¤ºçº¿ç²’ä½“DNAçªå˜è´Ÿæ‹…å¦‚ä½•å½±å“ä»£è°¢çµæ´»æ€§å’Œç™Œç—‡ï¼ˆå¦‚ç™½è¡€ç—…ï¼‰å‘ç”Ÿã€‚<br />
-  ç ”ç©¶å‘ç°æ³¡èœï¼ˆKimchiï¼‰é€šè¿‡è°ƒæ§å…ç–«ç³»ç»Ÿï¼Œå¯ä¿ƒè¿›äººä½“å…ç–«åŠŸèƒ½ã€‚<br />
-  å¼€å‘æ–°å‹æ£€æµ‹æ–¹æ³•ï¼Œé€šè¿‡è¿½è¸ªå¤§è„‘ç³–åˆ©ç”¨æƒ…å†µï¼Œå®ç°é˜¿å°”èŒ¨æµ·é»˜ç—…ï¼ˆAlzheimerâ€™sï¼‰çš„æ—©æœŸé¢„è­¦ã€‚</p>
<p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š<br />
-  UltraMarathonRTÂ® Direct RNAâ€‘Seq Kit å®ç°äº†Nanoporeç›´æ¥RNAæµ‹åºçš„çªç ´ï¼Œæä¾›æ›´é•¿è¯»é•¿ã€æ›´å¤šå¼‚æ„ä½“ï¼Œå¹¶ä¿ç•™RNAä¿®é¥°ã€‚<br />
-  AIåœ¨ç™Œç—‡è¯Šæ–­çš„åŒæ—¶ï¼Œè¿˜èƒ½ä»ç—…ç†åˆ‡ç‰‡ä¸­æ¨æ–­æ‚£è€…äººå£ç»Ÿè®¡å­¦ä¿¡æ¯ã€‚</p>
            </div><h2>ğŸ“š åˆ†ç±»æµè§ˆ</h2>
<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§¬ æ•°æ®å‰æ²¿ (94æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>GSE268161 å•ç»†èƒåˆ†è¾¨ç‡ä¸‹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­æŠµæŠ—ä¸­ T ç»†èƒè€—ç«­çš„è½¬å½•è°ƒæ§ [ç¦»ä½“-scRNA]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€resistanceã€single-cellã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tzu-Yang Tseng ; Ching-Huang Hsieh ; Chia-Lang Hsu ; Yu-Ching Wu ; Chiun Hsu ; Hsuan-Cheng Huang ; Da-Liang Ou ; Hsueh-Fen JuanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTumor-specific CD8+ T lymphocytes are crucial for anti-cancer immunity but can lose cytotoxic function in the immunosuppressive tumor microenvironment. Immune checkpoint blockades (ICB), like anti-PD-1 therapy, enhance and prolong anti-tumor T cell responses. Despite its widespread clinical use, resistance to ICB develops in some patients, characterized by the proliferation of exhausted T cell (Tex). Here, we establish two single-cell murine hepatocellular carcinoma (HCC) models to explore regulatory network in Tex with ICB resistance. We uncover distinct T cell compositions, including both early and terminal Tex subsets, following prolonged ICB treatment, and reveal the differentiation trajectory of Tex subsets. Finally, we not only identify transcription factor Runx2 and its downstream targets as contributors to T cell exhaustion in both models, but discover ICB response correlates to Runx2 level in human tumor-infiltrating lymphocytes. These findings elucidate Runx2 regulates T cell exhaustion in response to prolonged ICB treatment, influencing ICB effICBency, and suggest potential targets for combination therapy alongside ICB in HCC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268161" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> â­ <strong>GSE268160 å•ç»†èƒåˆ†è¾¨ç‡ä¸‹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­è€è¯ä¸­ T ç»†èƒè€—ç«­çš„è½¬å½•è°ƒæ§ [ex vivo-scATAC]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€resistanceã€single-cellã€scATAC<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tzu-Yang Tseng ; Ching-Huang Hsieh ; Chia-Lang Hsu ; Yu-Ching Wu ; Chiun Hsu ; Hsuan-Cheng Huang ; Da-Liang Ou ; Hsueh-Fen JuanSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusTumor-specific CD8+ T lymphocytes are crucial for anti-cancer immunity but can lose cytotoxic function in the immunosuppressive tumor microenvironment. Immune checkpoint blockades (ICB), like anti-PD-1 therapy, enhance and prolong anti-tumor T cell responses. Despite its widespread clinical use, resistance to ICB develops in some patients, characterized by the proliferation of exhausted T cell (Tex). Here, we establish two single-cell murine hepatocellular carcinoma (HCC) models to explore regulatory network in Tex with ICB resistance. We uncover distinct T cell compositions, including both early and terminal Tex subsets, following prolonged ICB treatment, and reveal the differentiation trajectory of Tex subsets. Finally, we not only identify transcription factor Runx2 and its downstream targets as contributors to T cell exhaustion in both models, but discover ICB response correlates to Runx2 level in human tumor-infiltrating lymphocytes. These findings elucidate Runx2 regulates T cell exhaustion in response to prolonged ICB treatment, influencing ICB effICBency, and suggest potential targets for combination therapy alongside ICB in HCC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268160" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> â­ <strong>GSE268165 å•ç»†èƒåˆ†è¾¨ç‡ä¸‹å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­è€è¯ä¸­Tç»†èƒè€—ç«­çš„è½¬å½•è°ƒæ§</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€resistanceã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSeries Type : Expression profiling by high throughput sequencing ; Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThis SuperSeries is composed of the SubSeries listed below.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268165" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> â­ <strong>GSE268163 å…ç–«æ£€æŸ¥ç‚¹é˜»æ–­æŠµæŠ—ä¸­ T ç»†èƒè€—ç«­çš„è½¬å½•è°ƒæ§ï¼ˆå•ç»†èƒåˆ†è¾¨ç‡ï¼‰[ä½“å†…]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmuneã€T cellã€resistanceã€single-cell<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Tzu-Yang Tseng ; Ching-Huang Hsieh ; Chia-Lang Hsu ; Yu-Ching Wu ; Chiun Hsu ; Hsuan-Cheng Huang ; Da-Liang Ou ; Hsueh-Fen JuanSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusTumor-specific CD8+ T lymphocytes are crucial for anti-cancer immunity but can lose cytotoxic function in the immunosuppressive tumor microenvironment. Immune checkpoint blockade (ICB), like anti-PD-1 therapy, enhance and prolong anti-tumor T cell responses. Despite its widespread clinical use, resistance to ICB develops in some patients, characterized by the proliferation of exhausted T cell (Tex). Here, we establish two single-cell murine hepatocellular carcinoma (HCC) models to explore regulatory network in Tex with ICB resistance. We uncover distinct T cell compositions, including both early and terminal Tex subsets, following prolonged ICB treatment, and reveal the differentiation trajectory of Tex subsets. Finally, we not only identify transcription factor Runx2 and its downstream targets as contributors to T cell exhaustion in both models, but discover ICB response correlates to Runx2 level in human tumor-infiltrating lymphocytes. These findings elucidate Runx2 regulates T cell exhaustion in response to prolonged ICB treatment, influencing ICB effICBency, and suggest potential targets for combination therapy alongside ICB in HCC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE268163" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> â­ <strong>GSE308675 ä¹³é…¸æ˜¯ä¸€ç§ä»£è°¢-è¡¨è§‚é—ä¼ ä¿¡å·ï¼Œå®ƒå°†é«˜å¼ºåº¦é—´æ­‡è®­ç»ƒä¸ä»¥ miRNA ä¸ºä¸­å¿ƒçš„éª¨éª¼è‚Œç”²åŸºåŒ–ç»„å’Œè½¬å½•ç»„é‡å¡‘è”ç³»èµ·æ¥ [ç”²åŸºåŒ–å¾®ç èŠ¯ç‰‡]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šmetabolicã€transcriptomeã€epigeneticã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Lei Zhou ; Radak ZsoltSeries Type : Methylation profiling by arrayOrganism : Mus musculusLactate, a major exercise-derived metabolite, has been proposed to couple cellular metabolism to gene regulation, yet its direct impact on skeletal muscle remains unclear. Male mice underwent six-week interventions (Control, lactate, HIIT, MCT1/2 inhibition, or HIIT+inhibition). We profiled gastrocnemius DNA methylation, mRNA-seq and miRNA-seq, and assessed signaling proteins, metabolites, and running performance. Lactate and HIIT each induced broad, site-specific remodeling of the methylome and transcriptome with substantial overlap at promoter CpGs and among DEGs. Promoter methylation changes showed weak coupling to steady-state mRNA, whereas integrative analyses revealed robust anti-directional miRNAâ€“mRNA networks and enriched for chromatin/epigenetic regulators, identifying a lactate-driven miRNA axis as a proximate regulator of transcriptional output. At the protein level, lactate selectively increased TET2 and DNMT3A and activated PAX7, VEGF, and AKTâ€“S6 signaling, consistent with integrative miRNAâ€“mRNA findings. HIIT increased TET1/2 and DNMT3A with DNMT3B reduction and uniquely enhanced mitochondrial/antioxidant signaling. Blocking MCT1/2 abrogated HIIT-induced methylome and miRNA remodeling and blunted transcriptomic and protein adaptation, demonstrating that intact lactate flux is required for exercise-evoked epigenetic and transcriptomic reprogramming. Despite molecular convergence, chronic lactate did not improve running performance, indicating that lactate is necessary but not sufficient for the full physiological adaptation of training. These findings position a lactateâ€“miRNA axis linking metabolic perturbation to epigenetic and transcriptional remodeling in skeletal muscle.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308675" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> â­ <strong>GSE297753 MEKæŠ‘åˆ¶å‰‚å¢å¼ºKRASçªå˜å‹è‚ºç™Œæ”¾å°„æ²»ç–—åçš„æŠ—è‚¿ç˜¤å…ç–«</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€immunityã€KRAS<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yawen Zheng ; Meili SunSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculus24 hours after the designated treatment, the LLC cells in four groups cultured in a 60 mm dish underwent two washes with PBS. Subsequently, 1 ml of TRIzol reagent was introduced. The solution was pipetted until it appeared clear, after which the mixture was transferred to an EP tube and stored at -80Â°C. The samples were then transported to BGI on dry ice for gene sequencing. Sequencing commenced once the samples successfully passed quality control assessments.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297753" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>7.</strong> â­ <strong>GSE313407 æˆå¹´å°é¼ å—æ§çš®å±‚å†²å‡»è§†è§‰ç©ºé—´è½¬å½•ç»„å­¦</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šspatialã€Visiumã€spatial transcriptomicsã€transcriptomics<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Savannah K Kounelis-Wuillaume ; Andrew M Frank ; Camille Alba ; Gauthaman Sukumar ; Matthew D Wilkerson ; Clifton L Dalgard ; Martin L DoughtySeries Type : OtherOrganism : Mus musculusHere we investigated the topographical relationship of early transcriptional responses to a single, focal TBI in mice by controlled cortical impact (CCI). Guided by the presence of the anterior commissure (AC) in coronal sections at the rostro-caudal point of impact, we compared gene expression changes in the neocortex (CTX) and corpus callosum-external capsule (CC-EC), striatum (STR) and AC. Injury-induced gene expression changes were detected in the CTX, CC-EC and STR but not AC and were principally segregated based on cytoarchitecture, and secondarily by proximity to the site of impact. Additionally, unbiased spatial clustering revealed a positive relationship between proximity to the impact and the number of acutely differentially expressed genes within the laminar CTX. Next, we examined the effects of systemic depletion of neutrophils and monocytes on spatial gene expression changes in the injured brain.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313407" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>8.</strong> â­ <strong>GSE169182 é€šè¿‡å•æ ¸ç”²åŸºåŒ–æµ‹åºç ”ç©¶å¤§è„‘è¡°è€çš„è¡¨è§‚é—ä¼ ç‰¹å¾ [CP-9mo-m-022]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€sequencingã€epigeneticã€methylation<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Wei Tian ; Anna Bartlett ; Jordan Altshul ; Rosa Gomez Castanon ; Joseph R Nery ; Jacinta D Lucero ; Julia K Osteen ; Huaming Chen ; M M Behrens ; Joseph R EckerSeries Type : Methylation profiling by high throughput sequencingOrganism : Mus musculusIllustrating aging effects on the epigenomic features of brain is critical to understand brain functional decline and neurodegeneration. Single nucleus methylation sequencing was applied to brain regions of mouse at the age of 2, 9 and 18 months. We use these data to identify the epigenomic changes with aging in mouse brains.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE169182" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>9.</strong> â­ <strong>GSE313718 ç²¾å‡†çº³ç±³ç–—æ³•é‡å¡‘è‚¿ç˜¤ç›¸å…³å·¨å™¬ç»†èƒä»¥é€†è½¬èƒ°è…ºç™Œä¸­çš„å…ç–«æŠ‘åˆ¶ [scRNA-seq]</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€cancerã€macrophageã€scRNA<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yunching Chen ; Hsin-Mei LeeSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusPancreatic ductal adenocarcinoma (PDAC) is characterized by an immunosuppressive stroma rich in tumor-associated macrophages (TAMs) that limit the therapeutic efficacy. We introduce a TAM-targeted nanotherapy platform that selectively delivers either a CSF1R inhibitor or the STING agonist cGAMP to immunosuppressive TAMs. While CSF1R inhibitorâ€“loaded nanoparticles efficiently depleted TAMs and produced moderate antitumor effects, TAM-targeted cGAMP nanoparticles reprogrammed TAMs into immune-stimulating effectors. This reprogramming normalized aberrant vasculature, alleviated desmoplasia, and enhanced infiltration and activation of cytotoxic immune cells. In combination with gemcitabine, PD-1 checkpoint blockade, or CAR-NK cell therapy, TAM-targeted STING activation provided an in situ immunostimulatory signal that markedly improved antitumor efficacy in preclinical PDAC models. Ex vivo efficacy in human PDAC tissues and a favorable safety profile show the translational potential of this TAM-targeted nanotherapy to overcome the immune desert of PDAC.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313718" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>10.</strong> â­ <strong>GSE314074 å…ç–«åŸºå› å¤šæ ·æ€§å’Œ STING1 å˜å¼‚ä½“åœ¨ä¸åŒé—ä¼ ç¥–å…ˆäººç¾¤ä¸­å¡‘é€ ç™Œç—‡å…ç–«åŠ›</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€immuneã€immunity<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xiaowen Hu ; Jie Huang ; Zhongyi Hu ; Lin ZhangSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensAs human populations migrated to diverse geographical regions, they encountered varying pathogens, leading to pronounced natural selection pressures on the immune system. Analysis of nonsynonymous single nucleotide polymorphisms (nsSNPs) across major geographically structured populations showed greater variation in immune-related genes than in non-immune genes, consistent with pathogen-driven selection, whereas cancer-related genes exhibited lower variation, reflecting evolutionary conservation of critical cellular functions. We prioritized nsSNPs in pattern recognition receptor genes based on population diversity and their association with type I interferon activity. Among the top-ranked variants were rs11554776, rs78233829, and rs7380824 in STING1, which demonstrated functional impacts on intrinsic cGAS-STING1-IFN signaling in cancer cells and potential influences on tumor immunity. We further conducted a genome-wide characterization of nsSNPs in immune-related genes across genetic ancestry populations and established a publicly accessible database. Our study suggests that genetic ancestry-related germline variations may influence cancer immunity and treatment, supporting their consideration in personalized medicine.<br />
- ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314074" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<blockquote>
<p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 84 æ¡å†…å®¹ï¼Œè¯¦è§ <a href="#æ›´å¤š-æ•°æ®å‰æ²¿">æ–‡æœ«</a></p>
</blockquote>
</div>
</details>

<details>
<summary style="text-align: right; direction: rtl; padding: 10px 15px; background: linear-gradient(135deg, #f8f9fa 0%, #e9ecef 100%); border-right: 4px solid #667eea; font-weight: 600; cursor: pointer; margin: 15px 0; border-radius: 6px;">ğŸ§ª åšå®¢æ›´æ–° (6æ¡)</summary>
<div class="details-content">
<h4>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨6æ¡ï¼‰</h4>
<p><strong>1.</strong> â­ <strong>RoCK å’Œ ROIâ€”â€”å•ç»†èƒè½¬å½•ç»„å­¦ï¼Œå¯å¯¹é€‰å®šçš„è½¬å½•æœ¬è¿›è¡Œå¤šé‡å¯Œé›†å’ŒåŒºåŸŸç‰¹å¼‚æ€§æµ‹åº</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencingã€single-cellã€transcriptomicsã€enrichment<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šEnhanced targeted capture and region-specific sequencing improve single-cell RNA sequencing resolution revealing key transcripts and regions of interest across diverse cell types...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rock-and-roi-single-cell-transcriptomics-with-multiplexed-enrichment-of-selected-transcripts-and-region-specific-sequencing/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>2.</strong> <strong>æŠ€æœ¯è¿›æ­¥æ­å¼€äº†çº¿ç²’ä½“DNAä¹‹è°œâ€”â€”æˆ‘ä»¬çš„â€œå¦ä¸€ä¸ªâ€åŸºå› ç»„</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šgenome<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šSingle cell RNA sequencing reveals how mitochondrial DNA mutation burden shapes metabolic flexibility and cancer growth, highlighting mtDNA as an active contributor to leukemogenesis...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/technology-advances-unlock-the-mystery-of-mitochondrial-dna-our-other-genome/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>3.</strong> <strong>RNAConnectæ¨å‡ºUltraMarathonRTÂ® Direct RNA-Seqè¯•å‰‚ç›’ï¼Œæ¨è¿›åŸºäºçº³ç±³å­”çš„å¤©ç„¶RNAæµ‹åºæŠ€æœ¯</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šA new kit improves direct RNA sequencing on Oxford Nanopore, delivering longer reads, more isoforms, and preserved RNA modifications through gentle low-temperature reverse...<br />
- ğŸ”— <a href="https://www.rna-seqblog.com/rnaconnect-launches-the-ultramarathonrt-direct-rna-seq-kit-to-advance-nanopore-based-native-rna-sequencing/" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>4.</strong> <strong>ä¸€é¡¹æ–°ç ”ç©¶æ­ç¤ºäº†æ³¡èœå¦‚ä½•å¢å¼ºå…ç–«ç³»ç»Ÿ</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šimmune<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šKimchi may do far more than add flavor to mealsâ€”it could help fine-tune the human immune system. A clinical study using advanced single-cell genetic analysis found that regular kimchi consumption strengthens immune defenses while preventing harmful overreactions. Researchers observed improved activity in key immune cells, with effects varying depending on fermentation methods.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251216081945.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>5.</strong> <strong>ä¸€é¡¹æ–°çš„æ£€æµ‹æ–¹æ³•æœ‰æœ›åœ¨ç—‡çŠ¶å‡ºç°å‰å‘ç°é˜¿å°”èŒ¨æµ·é»˜ç—…ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šAlzheimer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šScientists at Northern Arizona University are developing a promising new way to detect Alzheimerâ€™s disease earlier than ever beforeâ€”by tracking how the brain uses sugar. Using tiny particles in the blood called microvesicles, researchers may soon be able to gather brain-specific information without invasive procedures. If successful, this approach could transform Alzheimerâ€™s diagnosis, monitoring, and even prevention, much like how doctors manage heart disease today.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251216081943.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
<p><strong>6.</strong> <strong>äººå·¥æ™ºèƒ½ä¸ä»…èƒ½æ£€æµ‹ç™Œç—‡ï¼Œè¿˜èƒ½äº†è§£ä½ çš„ä¸ªäººä¿¡æ¯ã€‚</strong><br />
- âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…<br />
- ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancer<br />
- ğŸ“ <strong>æè¿°</strong>ï¼šAI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research shows these systems can infer patient demographics from pathology slides, leading to biased results for certain groups. The bias stems from how the models are trained and the data they see, not just from missing samples. Researchers also demonstrated a way to significantly reduce these disparities.<br />
- ğŸ”— <a href="https://www.sciencedaily.com/releases/2025/12/251217231230.htm" target="_blank" rel="noopener noreferrer">æŸ¥çœ‹åŸæ–‡</a></p>
</div>
</details>

<h2>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2>
<table class="keywords-table">
<thead>
<tr>
<th>å…³é”®è¯</th>
<th>å‡ºç°æ¬¡æ•°</th>
</tr>
</thead>
<tbody>
<tr>
<td>cancer</td>
<td>20</td>
</tr>
<tr>
<td>RNA-seq</td>
<td>12</td>
</tr>
<tr>
<td>single-cell</td>
<td>11</td>
</tr>
<tr>
<td>sequencing</td>
<td>9</td>
</tr>
<tr>
<td>immune</td>
<td>9</td>
</tr>
<tr>
<td>T cell</td>
<td>8</td>
</tr>
<tr>
<td>resistance</td>
<td>8</td>
</tr>
<tr>
<td>epigenetic</td>
<td>8</td>
</tr>
<tr>
<td>methylation</td>
<td>6</td>
</tr>
<tr>
<td>transcriptomics</td>
<td>5</td>
</tr>
<tr>
<td>metabolic</td>
<td>5</td>
</tr>
<tr>
<td>carcinoma</td>
<td>5</td>
</tr>
<tr>
<td>scRNA</td>
<td>4</td>
</tr>
<tr>
<td>Alzheimer</td>
<td>4</td>
</tr>
<tr>
<td>tumor</td>
<td>4</td>
</tr>
<tr>
<td>transcriptome</td>
<td>4</td>
</tr>
<tr>
<td>genome</td>
<td>3</td>
</tr>
<tr>
<td>regex:onco(logy</td>
<td>logist</td>
</tr>
<tr>
<td>aging</td>
<td>3</td>
</tr>
<tr>
<td>immunity</td>
<td>2</td>
</tr>
</tbody>
</table>
<hr />
<h2>ğŸ“ æ›´å¤šå†…å®¹</h2>
<details>
<summary><a name="æ›´å¤š-æ•°æ®å‰æ²¿"></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (84æ¡)</summary>
<div class="details-content">
<ul>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308673" target="_blank" rel="noopener noreferrer">GSE308673 ä¹³é…¸æ˜¯ä¸€ç§ä»£è°¢-è¡¨è§‚é—ä¼ ä¿¡å·ï¼Œå®ƒå°†é«˜å¼ºåº¦é—´æ­‡è®­ç»ƒä¸ä»¥miRNAä¸ºä¸­å¿ƒçš„éª¨éª¼è‚Œç”²åŸºåŒ–ç»„å’Œè½¬å½•ç»„é‡å¡‘è”ç³»èµ·æ¥</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293819" target="_blank" rel="noopener noreferrer">GSE293819 ç›‘æµ‹ä¹³è…ºç™Œä¸­å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚å¼•èµ·çš„å…¨èº«å…ç–«ååº”ï¼Œæ­ç¤ºå®¿ä¸»ååº”å’Œè€è¯æœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284115" target="_blank" rel="noopener noreferrer">GSE284115 é«“ç³»å¾®ç¯å¢ƒçš„å•ç»†èƒè½¬å½•ç»„å­¦æ­ç¤ºäº†ä¸‰é˜´æ€§ä¹³è…ºç™Œä¸­çš„è¡€ç®¡ç”Ÿæˆå¾®ç¯å¢ƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE271589" target="_blank" rel="noopener noreferrer">GSE271589 å•ç»†èƒ RNA æµ‹åºè§£æä¸ç³–å°¿ç—…å’Œè¡°è€è¿‡ç¨‹ä¸­é»è†œä¼¤å£æ„ˆåˆå¤±è°ƒç›¸å…³çš„ç»†èƒè¡¨å‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267517" target="_blank" rel="noopener noreferrer">GSE267517 æ¢ç´¢åµå·¢ç™Œä¸­è°ƒèŠ‚å…ç–«æ²»ç–—ååº”çš„è‚¿ç˜¤å†…åœ¨å› ç´ </a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE249803" target="_blank" rel="noopener noreferrer">GSE249803 ç©ºé—´è½¬å½•ç»„å­¦æ­ç¤ºè‚è„å†ç”Ÿè¿‡ç¨‹ä¸­è‚å°å¶çš„ç©ºé—´é‡å¡‘</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312098" target="_blank" rel="noopener noreferrer">GSE312098 é€šè¿‡åŒé‡é¶å‘ TROP2 å’Œ PERK æŠ‘åˆ¶ Wnt/Î²-catenin ä¿¡å·é€šè·¯å…‹æœæ™šæœŸç»“ç›´è‚ ç™Œçš„ ADC è€è¯æ€§ [TROP2+GSK RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313257" target="_blank" rel="noopener noreferrer">GSE313257 å•æ ¸è½¬å½•ç»„å­¦æ­ç¤ºåˆ›ä¼¤ååº”æ¿€éšœç¢ï¼ˆPTSDï¼‰æ‚£è€…æµ·é©¬ä½“ä¸­çš„å…ç–«å¤±è¡¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313958" target="_blank" rel="noopener noreferrer">GSE313958 Cas9 ç¼–è¾‘å’Œè½¬å½•ç»„çš„è”åˆå•ç»†èƒåˆ†ææ­ç¤ºäº†å¯¹åŸºå› è¡¨è¾¾çš„é¶å‘å’Œéé¶å‘æ•ˆåº”ï¼ˆRNA-seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309610" target="_blank" rel="noopener noreferrer">GSE309610 è‚¾ç»†èƒç™Œä¸­KRASçªå˜çš„ä¸´åºŠå’Œåˆ†å­ç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309446" target="_blank" rel="noopener noreferrer">GSE309446 ä¸€é¡¹é’ˆå¯¹æ™šæœŸ/è½¬ç§»æ€§éå°ç»†èƒè‚ºç™Œæ‚£è€…ï¼Œè¯„ä¼°è¥¿æ›²ä¼æ›¿å°¼è”åˆæ›¿é›·åˆ©ç å•æŠ—å’Œå¤šè¥¿ä»–èµ›æ²»ç–—è·å¾—æ€§PD-(L)1è€è¯çš„IIæœŸä¸´åºŠç ”ç©¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308914" target="_blank" rel="noopener noreferrer">GSE308914 å°é¼ å¿ƒè‚Œæ¢—æ­»åå¿ƒè„è½¬å½•ç»„çš„æ—¶é—´åŠ¨æ€å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300565" target="_blank" rel="noopener noreferrer">GSE300565 MRPL37 é€šè¿‡è°ƒèŠ‚çº¿ç²’ä½“èƒ½é‡ä»£è°¢ä¿ƒè¿›è‚ç»†èƒç™Œè¿›å±•</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296212" target="_blank" rel="noopener noreferrer">GSE296212 LINE-1 åŸºå› åº§è½¬å½•ä¿ƒè¿›è‡´ç™ŒæŸ“è‰²è´¨ç»“æ„å½¢æˆ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295052" target="_blank" rel="noopener noreferrer">GSE295052 èŠè¯é…šåœ¨å†…è´¨ç½‘åº”æ¿€æ¡ä»¶ä¸‹é€šè¿‡ CLGN/NF-ÎºB é€šè·¯å½±å“è‚ç»†èƒç™Œç»†èƒå¢æ®–å’Œå‡‹äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293262" target="_blank" rel="noopener noreferrer">GSE293262 ç”²åŸºè‹¯ä¸™èƒºæˆç˜¾è€…çš„å…¨åŸºå› ç»„DNAç”²åŸºåŒ–è°±åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE292020" target="_blank" rel="noopener noreferrer">GSE292020 ç»“ç›´è‚ ç™Œç±»å™¨å®˜é©±åŠ¨NKç»†èƒä¸­æ‚£è€…ç‰¹å¼‚æ€§çš„ç‚ç—‡ã€ç»†èƒæ¯’æ€§å’Œç»„ç»‡é©»ç•™ç¨‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313770" target="_blank" rel="noopener noreferrer">GSE313770 è¡°è€é›„æ€§å°é¼ è„‘çš„å•ç»†èƒå¤šç»„å­¦å’Œå¤šåŒºåŸŸå›¾è°±</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313691" target="_blank" rel="noopener noreferrer">GSE313691 T ç»†èƒè€—ç«­è¿‡ç¨‹ä¸­ 5â€™ TOP mRNA çš„ç¿»è¯‘ä¸‹è°ƒ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313455" target="_blank" rel="noopener noreferrer">GSE313455 è¿åŠ¨é€šè¿‡éª¨éª¼è‚Œæ¥æºçš„ç»†èƒå¤–å›Šæ³¡å¢å¼ºå°èƒ¶è´¨ç»†èƒæ¸…é™¤æ–‘å—ï¼Œä»è€Œç¼“è§£é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ çš„è®¤çŸ¥åŠŸèƒ½éšœç¢ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311016" target="_blank" rel="noopener noreferrer">GSE311016 é€šè¿‡åŒé‡é¶å‘ TROP2 å’Œ PERK æŠ‘åˆ¶ Wnt/Î²-catenin ä¿¡å·é€šè·¯å…‹æœæ™šæœŸç»“ç›´è‚ ç™Œçš„ ADC è€è¯æ€§</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309239" target="_blank" rel="noopener noreferrer">GSE309239 é«˜ç»´åˆ†ææ­ç¤ºäº†äººç±»è‚ é“å•æ ¸åå™¬ç»†èƒç¾¤çš„å¼‚è´¨æ€§ã€è°±ç³»ç‰¹å¼‚æ€§å‰ä½“ç»†èƒå’Œç‚ç—‡è¯±å¯¼çš„å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306665" target="_blank" rel="noopener noreferrer">GSE306665 å¥³æ€§è‚ é“æ•æ„Ÿæ€§å¢å¼ºçš„ç»†èƒåŸºç¡€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE279550" target="_blank" rel="noopener noreferrer">GSE279550 ç¥ç»å…ƒ APOE4 è¯±å¯¼çš„æ—©æœŸæµ·é©¬ç½‘ç»œè¿‡åº¦å…´å¥‹åœ¨é˜¿å°”èŒ¨æµ·é»˜ç—…å‘ç—…æœºåˆ¶ä¸­çš„ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314051" target="_blank" rel="noopener noreferrer">GSE314051 åºåˆ—å’ŒåŒ–å­¦ç‰¹å¼‚æ€§å®šä¹‰äº†å›ºæœ‰æ— åºåŒºåŸŸçš„åŠŸèƒ½å›¾è°± [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314023" target="_blank" rel="noopener noreferrer">GSE314023 è†³é£Ÿä¸­ç‰¹å®šæ°¨åŸºé…¸çš„ç¼ºä¹ä¼šè¯±å¯¼ä¸åŒçš„ä»£è°¢å’ŒæŸ“è‰²è´¨çŠ¶æ€</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313971" target="_blank" rel="noopener noreferrer">GSE313971 æŠ—åŸç»“åˆåŸŸçš„åˆç†é‡æ–°è®¾è®¡æé«˜äº†CD22-CARçš„ä½“å†…ç–—æ•ˆ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314188" target="_blank" rel="noopener noreferrer">GSE314188 ä½å‰‚é‡ ATG æ²»ç–—ååº”è€…åœ¨ 1 å‹ç³–å°¿ç—…ä¸­è¯±å¯¼ CD4+ T ç»†èƒè€—ç«­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313955" target="_blank" rel="noopener noreferrer">GSE313955 Cas9 ç¼–è¾‘å’Œè½¬å½•ç»„çš„è”åˆå•ç»†èƒåˆ†ææ­ç¤ºäº†å¯¹åŸºå› è¡¨è¾¾çš„é¶å‘å’Œéé¶å‘æ•ˆåº” (rhAmpSeq)</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311535" target="_blank" rel="noopener noreferrer">GSE311535 ç³–å°¿ç—…æ‚£è€…äººåŠ¨è„‰ç²¥æ ·ç¡¬åŒ–é¢ˆåŠ¨è„‰æ–‘å—ç»„ç»‡çš„ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE311201" target="_blank" rel="noopener noreferrer">GSE311201 æŠ—HER2/neu TCR-Tç»†èƒçš„ä½œç”¨ï¼šè½¬å½•ç‰¹å¾ã€åˆ†æ³Œç»„å­¦å’Œä½“å†…è‚¿ç˜¤æŠ‘åˆ¶çš„å…³è”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310457" target="_blank" rel="noopener noreferrer">GSE310457 è„‚è‚ªç»„ç»‡æ¥æºçš„microRNAä½œä¸º2å‹ç³–å°¿ç—…çš„è¡¨è§‚é—ä¼ è°ƒèŠ‚å› å­[DPDR_smallSeq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310456" target="_blank" rel="noopener noreferrer">GSE310456 è„‚è‚ªç»„ç»‡æ¥æºçš„microRNAä½œä¸º2å‹ç³–å°¿ç—…çš„è¡¨è§‚é—ä¼ è°ƒèŠ‚å› å­[DPDR_RNASEQ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310455" target="_blank" rel="noopener noreferrer">GSE310455 è„‚è‚ªç»„ç»‡æ¥æºçš„microRNAä½œä¸º2å‹ç³–å°¿ç—…çš„è¡¨è§‚é—ä¼ è°ƒèŠ‚å› å­[3T3_RNASeq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE310390" target="_blank" rel="noopener noreferrer">GSE310390 è„‚è‚ªç»„ç»‡æ¥æºçš„microRNAä½œä¸º2å‹ç³–å°¿ç—…çš„è¡¨è§‚é—ä¼ è°ƒèŠ‚å› å­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309891" target="_blank" rel="noopener noreferrer">GSE309891 SBFIæŠ‘åˆ¶å‰‚é‡ç¼–ç¨‹å‰åˆ—è…ºç™Œçš„è½¬å½•ç»„å›¾è°±ï¼Œå¯¼è‡´ç»†èƒæ­»äº¡</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309799" target="_blank" rel="noopener noreferrer">GSE309799 OR7A10 GPCR å·¥ç¨‹æ”¹é€ å¢å¼º CAR-NK ç–—æ³•å¯¹æŠ—å®ä½“ç˜¤ [scRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309566" target="_blank" rel="noopener noreferrer">GSE309566 å¯¹å¾ªç¯ T ç»†èƒåº“ä¸­ç—…æ¯’ CD4 T ç»†èƒè¡¨ä½ç‰¹å¼‚æ€§ TCR CDR3Î² åº“çš„æ·±å…¥æ¢ç´¢</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308723" target="_blank" rel="noopener noreferrer">GSE308723 æ–‘é©¬é±¼çŸ­æš‚æš´éœ²äºè¥¿é…æ™®å…°åï¼Œç¥ç»å’Œä»£è°¢åŸºå› è¡¨è¾¾å‘ç”ŸæŒç»­ä¸”å‰‚é‡ä¾èµ–æ€§çš„å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307268" target="_blank" rel="noopener noreferrer">GSE307268 å°é¼ å®éªŒæ€§å¿ƒè‚Œæ¢—æ­»â€”â€”å‡æ‰‹æœ¯å·¦å¿ƒå®¤ç»„ç»‡å’Œæ¢—æ­»åŒºçš„RNAæµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307265" target="_blank" rel="noopener noreferrer">GSE307265 å°é¼ å®éªŒæ€§å¿ƒè‚Œæ¢—æ­» - è‚¾è„ RNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306862" target="_blank" rel="noopener noreferrer">GSE306862 ç”¨ç–«è‹—åºåˆ—ä¸€è‡´çš„å…±åŒå…±è¯†æ ¸è›‹ç™½å’Œè¡€å‡ç´ è¿›è¡ŒåˆæˆDNAå…±å…ç–«ï¼Œåªéœ€ä¸€æ¬¡å…ç–«å³å¯ä¿æŠ¤å°é¼ å…å—è‡´å‘½æ€§æµæ„Ÿç—…æ¯’æ„ŸæŸ“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306570" target="_blank" rel="noopener noreferrer">GSE306570 é€šè¿‡è”åˆç§ç³»é¶å‘å…ç–«åŒæ—¶è¯±å¯¼å¤šç§å¹¿è°±ä¸­å’ŒæŠ—ä½“å‰ä½“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305469" target="_blank" rel="noopener noreferrer">GSE305469 åº”æ¿€æ¡ä»¶ä¸‹èƒƒç™Œç»†èƒçš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303388" target="_blank" rel="noopener noreferrer">GSE303388 KIAA0319 é€šè¿‡ä¸é˜…è¯»éšœç¢ç›¸å…³çš„åŸºå› ç½‘ç»œåœ¨çš®å±‚ç¥ç»å…ƒæˆç†Ÿå’Œçªè§¦å‘è‚²ä¸­å‘æŒ¥å…³é”®ä½œç”¨</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE302693" target="_blank" rel="noopener noreferrer">GSE302693 åŒè‰²èœ¡èŠåœ¨å‘è‚²ã€ä»£è°¢å’ŒåŸºå› è¡¨è¾¾æ°´å¹³ä¸Šé€‚åº”ç£·é…¸ç›ç¼ºä¹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301349" target="_blank" rel="noopener noreferrer">GSE301349 ä»çš®ä¸‹ç§»æ¤åˆ°åŸä½ç§»æ¤ï¼šå¼¥åˆè‚ºç™Œç ”ç©¶ä¸äººç±»ç–¾ç—…ä¹‹é—´çš„å·®è· [å°é¼ ]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE301347" target="_blank" rel="noopener noreferrer">GSE301347 ä»çš®ä¸‹åˆ°åŸä½ï¼šå¼¥åˆè‚ºç™Œç ”ç©¶ä¸­ä¸äººç±»ç–¾ç—…çš„å·®è· [äººç±»]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300095" target="_blank" rel="noopener noreferrer">GSE300095 åŸºäº PHF23 å­˜åœ¨å’Œæ°¨åŸºé…¸é¥¥é¥¿çš„è½¬å½•ç»„åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300094" target="_blank" rel="noopener noreferrer">GSE300094 PHF23 çš„åŸºå› ç»„ç»“åˆ/å ä½è°±åˆ†æä»¥åŠåŸºäº PHF23 å­˜åœ¨æƒ…å†µä¸‹ H3K27ac çš„å˜åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300093" target="_blank" rel="noopener noreferrer">GSE300093 CRISPRiç­›é€‰é‰´å®šè‡ªå™¬é€šé‡çš„è¡¨è§‚é—ä¼ è°ƒæ§å› å­</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE300092" target="_blank" rel="noopener noreferrer">åŸºäºPHF23å­˜åœ¨çš„ATAC-seqæŸ“è‰²è´¨å¯åŠæ€§åˆ†æGSE300092</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299624" target="_blank" rel="noopener noreferrer">GSE299624 T3aè‚¾ç»†èƒç™Œä¸­è„‚è‚ªæµ¸æ¶¦ä¸é™è„‰æµ¸æ¶¦çš„ä¸åŒé¢„åå’Œåˆ†å­ç‰¹å¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297941" target="_blank" rel="noopener noreferrer">GSE297941 SBFI æŠ‘åˆ¶å‰‚é‡ç¼–ç¨‹å‰åˆ—è…ºç™Œçš„è½¬å½•ç»„å›¾è°±ï¼Œå¯¼è‡´ç»†èƒæ­»äº¡ [SBFI-1143]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297940" target="_blank" rel="noopener noreferrer">GSE297940 SBFI æŠ‘åˆ¶å‰‚é‡ç¼–ç¨‹å‰åˆ—è…ºç™Œçš„è½¬å½•ç»„å›¾è°±ï¼Œå¯¼è‡´ç»†èƒæ­»äº¡ [SBFI-103]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296794" target="_blank" rel="noopener noreferrer">GSE296794 RNA-RNA ç›¸äº’ä½œç”¨ç»„æ–¹æ³•æä¾›äº†ä½“å†…è¯æ®ï¼Œè¯æ˜ Hfq è¾¹ç¼˜é¢åœ¨ sRNA-mRNA é…å¯¹ä¸­èµ·å…³é”®ä½œç”¨ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296484" target="_blank" rel="noopener noreferrer">GSE296484 ç‰›è¡€ä¸­DNAç”²åŸºåŒ–å˜åŒ–ä¸å¹´é¾„å’Œç–¾ç—…çš„å…³ç³»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296336" target="_blank" rel="noopener noreferrer">GSE296336 äººç±»é—´æœŸå’Œä¸­æœŸæŸ“è‰²ä½“ä¸­æ ¸å°ä½“ç»„ç»‡çš„å·®å¼‚ [RNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296211" target="_blank" rel="noopener noreferrer">GSE296211 LINE-1 åŸºå› åº§è½¬å½•ä¿ƒè¿›è‡´ç™ŒæŸ“è‰²è´¨ç»“æ„å½¢æˆ [L1CaP-C]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296210" target="_blank" rel="noopener noreferrer">GSE296210 LINE-1 åŸºå› åº§è½¬å½•ä¿ƒè¿›è‡´ç™ŒæŸ“è‰²è´¨ç»“æ„å½¢æˆ [ChIRP-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE293553" target="_blank" rel="noopener noreferrer">GSE293553 é£Ÿç®¡é³çŠ¶ç»†èƒç™Œ (ESCC) ç»†èƒ RNA æµ‹åºï¼šTFAP2Î² è¿‡è¡¨è¾¾æˆ–å…¶ LLPS ç¼ºé™·çªå˜ä½“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290729" target="_blank" rel="noopener noreferrer">GSE290729 é£Ÿç®¡é³çŠ¶ç»†èƒç™Œ (ESCC) ç»†èƒè¿‡è¡¨è¾¾ TFAP2Î² æˆ–å…¶ LLPS ç¼ºé™·çªå˜ä½“çš„ ChIP-seq</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289021" target="_blank" rel="noopener noreferrer">GSE289021 Ig E ä»‹å¯¼å’Œé Ig E ä»‹å¯¼çš„ç‰›å¥¶è¿‡æ•å©´å„¿çš„å·®å¼‚æ€§ DNA ç”²åŸºåŒ–åŠå…¶ä¸è·å¾—æ€§è€å—çš„å…³ç³»</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE288962" target="_blank" rel="noopener noreferrer">GSE288962 è”åˆå…ç–«ç–—æ³•è¯±å¯¼å¹²é¢„åHIVæ§åˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286349" target="_blank" rel="noopener noreferrer">GSE286349 IFN-Î³ å¤„ç† MOLM-13 ç»†èƒå¯å¢å¼º HLA åŸºå› è¡¨è¾¾</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE281071" target="_blank" rel="noopener noreferrer">GSE281071 m6A mRNAç”²åŸºåŒ–ä¿®é¥°å‚ä¸çº¤ç»´è›‹ç™½åŸåˆæˆçš„åŸºå› ä»¥è°ƒèŠ‚å°é¼ è‚è„å†ç”Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE280902" target="_blank" rel="noopener noreferrer">GSE280902 æ‹‰ä¸è£”æ‚£è€…æµ¸æ¶¦æ€§ä¹³è…ºç™Œæ–°è¾…åŠ©åŒ–ç–—ååº”è½¬å½•ç»„å…ƒç‰¹å¾çš„é‰´å®š</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE264400" target="_blank" rel="noopener noreferrer">GSE264400 äººç±»é—´æœŸå’Œä¸­æœŸæŸ“è‰²ä½“ä¸­æ ¸å°ä½“ç»„ç»‡çš„å·®å¼‚ [RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE255109" target="_blank" rel="noopener noreferrer">GSE255109 RNA G-å››é“¾ä½“(rG4)é€šè¿‡ä»‹å¯¼æ ¸ç³–ä½“æš‚åœåŠ å‰§ç»†èƒè¡°è€[RNA-seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240242" target="_blank" rel="noopener noreferrer">GSE240242 NR1D1 æ•²ä½å¯¹ Xp11.2 æ˜“ä½è‚¾ç»†èƒç™Œç»†èƒç³» UOK109 å’Œ UOK120 åŸºå› è¡¨è¾¾çš„å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE236558" target="_blank" rel="noopener noreferrer">GSE236558 å°é¼ ä¸‰é˜´æ€§ä¹³è…ºç™Œéª¨è½¬ç§»å•ç»†èƒæ°´å¹³çš„åŸºå› è¡¨è¾¾è°±ã€‚</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314089" target="_blank" rel="noopener noreferrer">GSE314089 æ­ç¤ºé¶å‘ BDCA2 åœ¨æ²»ç–—è‡ªèº«å…ç–«æ€§ç–¾ç—…ä¸­çš„ä¸¤ç§æˆªç„¶ä¸åŒçš„ä½œç”¨ï¼šç›´æ¥æŠ‘åˆ¶ BDCA2 é˜³æ€§ B ç»†èƒå’Œé€šè¿‡å…¨é¢æŠ‘åˆ¶ I å‹å¹²æ‰°ç´ ä½¿ä¿ƒç‚æ€§å•æ ¸ç»†èƒæ¥æºçš„å·¨å™¬ç»†èƒæ­£å¸¸åŒ–</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312599" target="_blank" rel="noopener noreferrer">GSE312599 æ”¹å˜çš„MDC1ç›¸äº’ä½œç”¨å’ŒDNAä¿®å¤åŠŸèƒ½éšœç¢å¯¼è‡´å°å¶æ€§ä¹³è…ºç™Œå¯¹PARPæŠ‘åˆ¶å‰‚æ•æ„Ÿ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314225" target="_blank" rel="noopener noreferrer">GSE314225 è´å…‹æ°èºæ—‹çº¿è™«æ„ŸæŸ“åè°±ç³»è¿½è¸ªè®°å¿†æ€§ Th2 ç»†èƒçš„ RNA æµ‹åºï¼šIL-5 ä¸ IL-13 çš„æ¯”è¾ƒ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314191" target="_blank" rel="noopener noreferrer">GSE314191ï¼šCas9 ç¼–è¾‘å’Œè½¬å½•ç»„çš„è”åˆå•ç»†èƒåˆ†ææ­ç¤ºäº†å…¶å¯¹åŸºå› è¡¨è¾¾çš„é¶å‘å’Œéé¶å‘æ•ˆåº”</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE314064" target="_blank" rel="noopener noreferrer">GSE314064ï¼šä¸åŒç”Ÿæ®–èƒ½åŠ›ç»µç¾Šåµå·¢å¤–æ³Œä½“lncRNAå’ŒmRNAè¡¨è¾¾ç‰¹å¾åŠç”Ÿç‰©ä¿¡æ¯å­¦åˆ†æ</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313692" target="_blank" rel="noopener noreferrer">GSE313692 T ç»†èƒè€—ç«­è¿‡ç¨‹ä¸­ 5â€™ TOP mRNA çš„ç¿»è¯‘ä¸‹è°ƒ [Ribo-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313456" target="_blank" rel="noopener noreferrer">GSE313456 è¿åŠ¨é€šè¿‡éª¨éª¼è‚Œæ¥æºçš„ç»†èƒå¤–å›Šæ³¡å¢å¼ºå°èƒ¶è´¨ç»†èƒæ¸…é™¤æ–‘å—ï¼Œä»è€Œç¼“è§£é˜¿å°”èŒ¨æµ·é»˜ç—…å°é¼ çš„è®¤çŸ¥åŠŸèƒ½éšœç¢ [miRNA-Seq]</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306194" target="_blank" rel="noopener noreferrer">GSE306194 é€šè¿‡å‘ç°æ§åˆ¶è‚ºæ³¡ä¸Šçš®ç»†èƒå‘½è¿çš„å› å­æ¨è¿›è‚ºç»„ç»‡å·¥ç¨‹ï¼ˆAT2 scRNA-seqï¼‰</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE299367" target="_blank" rel="noopener noreferrer">GSE299367 ç¼ºæ°§æ¿€æ´»çš„ç¡¬åŒ–è›‹ç™½Aä»‹å¯¼å¿ƒå¤–è†œç¥–ç»†èƒåˆ†åŒ–ä¸ºä¸€ç§ç‹¬ç‰¹çš„å¿ƒè„è¡€ç®¡å‘¨å›´ç»†èƒç±»å‹</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298395" target="_blank" rel="noopener noreferrer">GSE298395 å¹´è½»å’Œè€å¹´è‚Œè‚‰äº§ç”Ÿçš„å¤–æ³Œä½“çš„ miRNA æµ‹åº</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295428" target="_blank" rel="noopener noreferrer">GSE295428 å¤ªç©ºé£è¡Œå¯¹ä¸åŒå¹´é¾„é˜¶æ®µçš„ç»†èƒå¤–åŸºè´¨å’Œå…ç–«ç³»ç»Ÿäº§ç”Ÿç³»ç»Ÿæ€§å½±å“</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284663" target="_blank" rel="noopener noreferrer">GSE284663 æ•´åˆå…ƒç»„å­¦æ­ç¤ºå”¾æ¶²ä¹³æ†èŒæ”¹å–„å°¼ç½—ç½—éé±¼è‚ é“å¥åº·çš„æœºåˆ¶</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE284661" target="_blank" rel="noopener noreferrer">GSE284661 RNAæµ‹åºï¼Œé’ˆå¯¹æš´éœ²äºå‡¡å¾·ä»–å°¼çš„é‡ç”Ÿå‹C57BL/6Jå°é¼ çš„è‚è„æ ·æœ¬è¿›è¡ŒRNAæµ‹åº</a></li>
</ul>
</div>
</details>

<hr />
<p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2025-12-18 21:35</em><br />
<em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p>
    </div>
</body>
</html>